Assistant Professor, Chapman University School of Pharmacy, Associate Project Scientist, University of California
BIOGRAPHY
Transferrin Receptor-Mediated Drug Delivery for Alzheimer's Disease
Presented at:
Drug Discovery & Development Virtual Event Series 2025
Speaker
Abstract
The presentation will focus on the use of receptor-mediated targeted drug delivery to deliver large molecules to the brain for Alzheimer's disease. Specifically, the presentation will cover transferrin receptor-mediated delivery of antibody-drug fusion proteins, their effects in mouse models of Alzheimer's disease, potential side effects, and challenges associated with chronic dosing.
Learning Objectives:
1. Discuss the Mechanism and Application of Transferrin Receptor-Mediated Drug Delivery.
- By the end of the presentation, participants will be able to explain how transferrin receptor-mediated delivery of antibody-drug fusion proteins facilitates the transport of large molecules to the brain for the treatment of Alzheimer's disease.
2. Evaluate the Efficacy and Challenges of Chronic Dosing in Alzheimer's Disease Models.
- By the end of the presentation, participants will be able to assess the effects of transferrin receptor-mediated drug delivery in mouse models of Alzheimer's disease, identify potential side effects, and discuss the challenges associated with chronic dosing.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
FEB 25, 2025 | 1:00 PM
Quality efforts in the clinical laboratory are always under the microscope- a hyper-focus for laboratorians from start to finish. Recognizing the external factors that affect hemostasis test...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...